Sonova says surge of Delta cases in US hasn't affected hearing aid market

The Covid-19 variant is not disrupting the company's sales on the US market.

Photo: Arnd Wiegmann/Reuters/Ritzau Scanpix

The spread of the Delta variant of the coronavirus has begun disrupting plans to reopen all over the world. For example, in Asia, several countries have had to impose restrictions and introduce lockdowns – again.

This is also being felt by the hearing aid manufacturers that are facing huge challenges in certain markets.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs